FATE
Fate Therapeutics, Inc. · Healthcare
CFO Edward J Dulac III sold $25K of Fate Therapeutics, Inc.
Sold$25,029
$4.83Price
5,182Shares
−4%Stake
What FATE did after the filing
- The stock from Thu, Jul 6 close, $4.67
- −40.5%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Aug 17 close.
Traded Wed, Jul 5. Filed Thu, Jul 6, 1:18 PM ET, during the session. Returns use the Jul 6 close and the Aug 17 close. Not investment advice.